SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Northwest Biotherapeutics Inc.
An SI Board Since August 2006
Posts SubjectMarks Bans Symbol
760 18 0 NWBO
Emcee:  John McCarthy Type:  Unmoderated
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
9From 2003 Northwest Biotherapeutics, Inc. to Present Favorable Data on EffectsJohn McCarthy-8/19/2006
8Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed GliJohn McCarthy-8/19/2006
7NWBT's Phase 2 Trial 36) Study of a Drug [DCVax®-Brain] to Treat GBM John McCarthy-8/19/2006
6continued from previous post (51) Evaluate the Efficacy and Safety of PhotodyJohn McCarthy-8/19/2006
5continued from previous post (38) Everolimus and Gefitinib in Treating PatienJohn McCarthy-8/19/2006
4continued from prior post .... (31) Temozolomide and Radiation Therapy With orJohn McCarthy-8/19/2006
3continued from prior post ..... (16) (Phase 3) Intratumoral Transferrin-CRM107John McCarthy-8/19/2006
2At the present time their are 58 trials (that I could find)related to GlioblastoJohn McCarthy-8/19/2006
1Hi - the purpose of this board is fivefold - (a) post information related to NJohn McCarthy-8/19/2006
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):